Marizyme, Inc.

Marizyme, Inc.verified

MRZM

Price:

$0.04

Market Cap:

$5.27M

Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and burns, acute ischemic stroke, deep vein thrombosis, and dissolving plaque and biofilms on teeth. In addition, it focuses on developing products to mitigate the effects of ischemia reperfusion injury in other grafting and transplantation surgeries, and o...[Read more]

Industry

Biotechnology

IPO Date

2010-11-10

Stock Exchange

PNK

Ticker

MRZM

The Enterprise Value as of November 2024 (TTM) for Marizyme, Inc. (MRZM) is 25.72M

According to Marizyme, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 25.72M. This represents a change of -13.32% compared to the average of 29.67M of the last 4 quarters.

Marizyme, Inc. (MRZM) Historical Enterprise Value (quarterly & annually)

How has MRZM Enterprise Value performed in the past?

The mean historical Enterprise Value of Marizyme, Inc. over the last ten years is 20.09M. The current 25.72M Enterprise Value has changed 12.70% with respect to the historical average. Over the past ten years (40 quarters), MRZM's Enterprise Value was at its highest in in the June 2022 quarter at 110.53M. The Enterprise Value was at its lowest in in the December 2017 quarter at -31983.66.

Quarterly (TTM)
Annual

Average

20.09M

Median

11.49M

Minimum

-31982.52

Maximum

64.35M

Marizyme, Inc. (MRZM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Marizyme, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 550.25%

Maximum Annual Enterprise Value = 64.35M

Minimum Annual Increase = -39731.94%

Minimum Annual Enterprise Value = -31982.52

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202323.12M-12.58%
202226.44M-57.78%
202162.64M-2.66%
202064.35M524.82%
201910.30M-18.75%
201812.68M-39731.94%
2017-31982.52-132.85%
201697.35K-91.55%
20151.15M550.25%
2014177.28K-76.14%

Marizyme, Inc. (MRZM) Average Enterprise Value

How has MRZM Enterprise Value performed in the past?

The current Enterprise Value of Marizyme, Inc. (MRZM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

37.40M

5-year avg

37.37M

10-year avg

20.09M

Marizyme, Inc. (MRZM) Enterprise Value vs. Peers

How is MRZM’s Enterprise Value compared to its peers?

Marizyme, Inc.’s Enterprise Value is less than NRx Pharmaceuticals, Inc. (0), greater than RenovaCare, Inc. (20.89M), greater than Aerovate Therapeutics, Inc. (8.73K), less than Scopus BioPharma Inc. (48.13M), less than Magenta Therapeutics, Inc. (0), less than Allena Pharmaceuticals, Inc. (0), greater than Akari Therapeutics, Plc (-107741.00), greater than Armata Pharmaceuticals, Inc. (-114170976.00), greater than Anebulo Pharmaceuticals, Inc. (-29461000.00), less than Processa Pharmaceuticals, Inc. (26.33M), less than Inhibikase Therapeutics, Inc. (204.77M), less than Sio Gene Therapies Inc. (45.92M), greater than Kaleido Biosciences, Inc. (831.36K), less than Tempest Therapeutics, Inc. (172.46M), greater than null (-15427292.00), greater than null (4.26K), greater than null (14.13M),

Build a custom stock screener for Marizyme, Inc. (MRZM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marizyme, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marizyme, Inc. (MRZM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marizyme, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Marizyme, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Marizyme, Inc. (MRZM)?

What is the 3-year average Enterprise Value for Marizyme, Inc. (MRZM)?

What is the 5-year average Enterprise Value for Marizyme, Inc. (MRZM)?

How does the current Enterprise Value for Marizyme, Inc. (MRZM) compare to its historical average?